Functional roles of the membrane-associated AAV protein MAAP

被引:0
作者
Lionel Galibert
Amira Hyvönen
Reetta A. E. Eriksson
Salla Mattola
Vesa Aho
Sami Salminen
Justin D. Albers
Sanna K. Peltola
Saija Weman
Tiina Nieminen
Seppo Ylä-Herttuala
Hanna P. Lesch
Maija Vihinen-Ranta
Kari J. Airenne
机构
[1] Kuopio Center for Gene and Cell Therapy,Department of Biological and Environmental Science and Nanoscience Center
[2] FinVector,A.I. Virtanen Institute for Molecular Sciences
[3] University of Jyvaskyla,Gene Therapy Unit and Research Center
[4] University of Eastern Finland,undefined
[5] Kuopio University Hospital,undefined
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
With a limited coding capacity of 4.7 kb, adeno-associated virus (AAV) genome has evolved over-lapping genes to maximise the usage of its genome. An example is the recently found ORF in the cap gene, encoding membrane-associated accessory protein (MAAP), located in the same genomic region as the VP1/2 unique domain, but in a different reading frame. This 13 KDa protein, unique to the dependovirus genus, is not homologous to any known protein. Our studies confirm that MAAP translation initiates from the first CTG codon found in the VP1 ORF2. We have further observed MAAP localised in the plasma membrane, in the membranous structures in close proximity to the nucleus and to the nuclear envelope by co-transfecting with plasmids encoding the wild-type AAV (wt-AAV) genome and adenovirus (Ad) helper genes. While keeping VP1/2 protein sequence identical, both inactivation and truncation of MAAP translation affected the emergence and intracellular distribution of the AAV capsid proteins. We have demonstrated that MAAP facilitates AAV replication and has a role in controlling Ad infection. Additionally, we were able to improve virus production and capsid integrity through a C-terminal truncation of MAAP while other modifications led to increased packaging of contaminating, non-viral DNA. Our results show that MAAP plays a significant role in AAV infection, with profound implications for the production of therapeutic AAV vectors.
引用
收藏
相关论文
共 176 条
[1]  
Casto BC(1967)Studies on the relationship between adeno-associated virus type I (AAV-1) and adenoviruses. I. Replication of AAV-1 in certain cell cultures and its effect on helper adenovirus Virology 32 52-59
[2]  
Atchison RW(1981)Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication J. Virol. 40 241-247
[3]  
Hammon WMD(1995)Minimum origin requirements for linear duplex AAV DNA replication in vitro Virology 209 692-695
[4]  
Buller RM(2006)In vitro replication of adeno-associated virus DNA Proc. Natl. Acad. Sci. 89 4673-4677
[5]  
Janik JE(2001)DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids EMBO J. 20 3282-3291
[6]  
Sebring ED(1991)Targeted integration of adeno-associated virus (AAV) into human chromosome 19 EMBO J. 10 3941-3950
[7]  
Rose JA(2010)Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome PLoS Pathog. 6 1-14
[8]  
Ward P(1990)The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity Cell 61 447-457
[9]  
Berns KI(2003)Characterization of the adenoassociated virus Rep protein complex formed on the viral origin of DNA replication Virology 313 364-376
[10]  
Hong G(2005)Mechanisms of adeno-associated virus genome encapsidation Curr. Gene Ther. 5 273-284